Ear prick therapy may slash Pre-Surgery jitters and opioid use
NCT ID NCT04836936
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests whether a special ear acupuncture technique, called auriculotherapy, can reduce anxiety in patients awaiting kidney surgery. Sixty adults scheduled for a nephrectomy will receive either a real or placebo version of the treatment. Researchers will measure anxiety levels and how much opioid pain medicine patients need after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- auriculotherapy (ear acupuncture using a cryopuncture device with nitrogen gas)
- What this could lead to
- If it works, this could offer a drug-free way to ease pre-surgery anxiety and reduce the need for opioids after surgery.
- What could go wrong
- This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The placebo group also gets a device, so the real effect may be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY PREOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UPMC Shadyside Hospital
Pittsburgh, Pennsylvania, 15232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who needs extra therapy after kidney cancer surgery?
- Can a Two-Drug combo outsmart advanced cancers?
- Can a rapid drug switch outsmart advanced kidney cancer?
- Can a new nucleotide analogue boost cancer treatment?
- Can a blast of radiation make immunotherapy work better against kidney cancer?
- Can reprogrammed immune cells take on hard-to-treat kidney cancer?